Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/22/25 15:24 | 7/22/25 | ETST | Health | Drug | Pharmaceutical Preparations | Saumat Giorgio R. | FL | DOT | CEO | 10 | P.m | 308 | 0.1863 | 0 | 1,655 | 1 | 122,930 | D | ||||||||||||||
7/9/25 16:34 | 7/8/25 | ETST | Health | Drug | Pharmaceutical Preparations | Sanchez Yovan Arturo | FL | D | 11 | P.m | 117 | 0.1484 | 0 | 790 | 87 | 1,700 | D | |||||||||||||||
3/11/25 06:10 | 3/10/25 | ETST | Health | Drug | Pharmaceutical Preparations | Tabraue Mario Guillermo | FL | DO | COO | 7 | P | 25 | 0.1937 | 0 | 131 | 1 | 12,422 | D | ||||||||||||||
3/7/25 06:02 | 3/4/25 | ETST | Health | Drug | Pharmaceutical Preparations | Rose Christopher Alan | FL | O | CTO | 2 | P | 10 | 0.1831 | 0 | 54 | 173 | 85 | D | ||||||||||||||
1/28/25 13:03 | 1/28/25 | ETST | Health | Drug | Pharmaceutical Preparations | Flores Ernesto L | FL | DO | CFO | 1 | P | 10 | 0.2300 | 0 | 43 | 84 | 95 | D | ||||||||||||||
1/10/25 18:25 | 1/8/25 | ETST | Health | Drug | Pharmaceutical Preparations | Cazeau Jeff P. H. | FL | H | Independ | 7 | P | 69 | 0.1496 | 0 | 464 | 319 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |